Business Description
Elevance Health Inc
NAICS : 524114
SIC : 6324
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.24 | |||||
Equity-to-Asset | 0.36 | |||||
Debt-to-Equity | 0.65 | |||||
Debt-to-EBITDA | 2.47 | |||||
Interest Coverage | 8.7 | |||||
Piotroski F-Score | 5/9 | |||||
Beneish M-Score | -2.95 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 14.6 | |||||
3-Year EBITDA Growth Rate | 11.2 | |||||
3-Year EPS without NRI Growth Rate | 22.4 | |||||
3-Year FCF Growth Rate | -9.2 | |||||
3-Year Book Growth Rate | 7.6 | |||||
Future 3-5Y EPS without NRI Growth Rate | 12.1 | |||||
Future 3-5Y Total Revenue Growth Rate | 5.5 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.32 | |||||
Dividend Payout Ratio | 0.06 | |||||
3-Year Dividend Growth Rate | 15.9 | |||||
Forward Dividend Yield % | 1.31 | |||||
5-Year Yield-on-Cost % | 0.65 | |||||
3-Year Average Share Buyback Ratio | 1.7 | |||||
Shareholder Yield % | 2.36 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Net Margin % | 3.64 | |||||
FCF Margin % | 1.36 | |||||
ROE % | 16.1 | |||||
ROA % | 5.68 | |||||
ROIC % | 8.65 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 19.86 | |||||
Forward PE Ratio | 13.44 | |||||
PE Ratio without NRI | 17.7 | |||||
Shiller PE Ratio | 26.35 | |||||
Price-to-Owner-Earnings | 117.8 | |||||
PEG Ratio | 1.62 | |||||
PS Ratio | 0.72 | |||||
PB Ratio | 3.01 | |||||
Price-to-Tangible-Book | 30.94 | |||||
Price-to-Free-Cash-Flow | 54.25 | |||||
Price-to-Operating-Cash-Flow | 34.84 | |||||
EV-to-EBIT | 15.68 | |||||
EV-to-Forward-EBIT | 12.13 | |||||
EV-to-EBITDA | 13.32 | |||||
EV-to-Forward-EBITDA | 11.38 | |||||
EV-to-Revenue | 0.83 | |||||
EV-to-Forward-Revenue | 0.82 | |||||
EV-to-FCF | 62.01 | |||||
Price-to-Projected-FCF | 0.96 | |||||
Price-to-DCF (Earnings Based) | 0.8 | |||||
Price-to-DCF (FCF Based) | 2.23 | |||||
Price-to-Median-PS-Value | 1.07 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.56 | |||||
Price-to-Graham-Number | 4.94 | |||||
Earnings Yield (Greenblatt) % | 6.38 | |||||
FCF Yield % | 1.88 | |||||
Forward Rate of Return (Yacktman) % | 16.84 |